PuSH - Publikationsserver des Helmholtz Zentrums München

Weckler, B.* ; Martin, R.J.* ; Kutzinski, M.* ; Bertrams, W.* ; Jung, A.L.* ; Pott, H.* ; Laakmann, K.* ; Schulte, L.N.* ; Ahnert, P.* ; Heider, D.* ; Ringshandl, S.* ; Seidemann, C.* ; Suttorp, N.* ; Witzenrath, M.* ; Wildberg, J.* ; Lehmann, M. ; Rohde, G.* ; Greulich, T.* ; Vogelmeier, C.* ; Schmeck, B.*

Eosinophil count as biomarker for risk stratification of community-acquired pneumonia: a prospective cohort study.

Pneumologie 79, S92 - S93 (2025)
Verlagsversion DOI
Background: Retrospective evidence suggests that eosinopenia is associated with worse outcomes in patients with community-acquired pneumonia (CAP). However, data about the relationship between blood eosinophil levels and well-established risk stratification scores for CAP are missing, and a suitable eosinophil count threshold for distinguishing high- from low-risk patients has not been determined yet. This study therefore investigated blood eosinophil count at hospital admission as a biomarker for risk stratification of CAP. Methods: Adult patients were recruited in a prospective observational multi-centre study on hospitalised CAP (PROGRESS). The correlation between blood eosinophil numbers at hospital admission as continuous variable and risk stratification scores was analysed. A continuous analysis of eosinophil numbers versus mortality and risk of mechanical ventilation was performed for threshold determination of eosinopenia as a biomarker for risk stratification. Based on this analysis, patients were allocated to an eosinopenia (≤ 50/µL) and non-eosinopenia (> 50/µL) group. Their baseline characteristics and outcomes were compared. Findings: Overall, 1763 (60.0% males, median age 63.0 years) patients were included. Eosinophil counts correlated inversely with CRB-65 (p<0·0001), CURB-65 (p<0·0001), PSI (p<0·0001), Infectious Disease Society of America/American Thoracic Society minor criteria (p<0·0001), SOFA (p<0·0001), and Quick SOFA (p=0·0155). An eosinophil count threshold of 50/µL was proven suitable for risk stratification: Eosinopenia (versus non-eosinopenia) was associated with increased in-hospital mortality (2·8% versus 1·2%; RR 2·29; p=0·0251), need for mechanical ventilation (14·7% versus 7·1%; RR 2·07; p<0·0001), and length of stay (8 versus 7 days; p=0·0048). After compensating for multiple confounders including glucocorticoid treatment in the multivariate analysis, eosinopenia≤50/µL (versus non-eosinopenia) correlated with an increased (p=0·0003) need for mechanical ventilation. Interpretation: In a prospective multicentre study, blood eosinophil count at hospital admission correlates with well-established risk stratification scores for CAP. Eosinopenia≤50/µL seems to be a promising biomarker for risk stratification.
Altmetric
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Meeting abstract
Schlagwörter Risk Stratification ; Stratification (seeds)
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 0934-8387
e-ISSN 1438-8790
Zeitschrift Pneumologie
Quellenangaben Band: 79, Heft: S 01, Seiten: S92 - S93 Artikelnummer: , Supplement: ,
Verlag Thieme
Begutachtungsstatus Peer reviewed
POF Topic(s) 30202 - Environmental Health
Forschungsfeld(er) Lung Research
PSP-Element(e) G-501600-005
Erfassungsdatum 2025-06-18